Apexigen, Inc. Comprehensive Income
Apexigen, Inc. reported Comprehensive Income of -$6.05 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-08-10
- Apexigen, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$6.05M.
- Apexigen, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$6.05M.
- Apexigen, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$6.44M.
- Apexigen, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$8.49M.
- Apexigen, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$32.06M.
- Apexigen, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$28.92M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$6.05M 10-Q · filed 2023-08-10 | -$12.10M 10-Q · filed 2023-08-10 | -$18.54M derived: sum of 3 quarters · filed 2023-08-10 | -$27.03M derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | -$6.05M 10-Q · filed 2023-05-15 | -$12.49M derived: sum of 2 quarters · filed 2023-05-15 | -$20.98M derived: sum of 3 quarters · filed 2023-05-15 | -$29.10M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | -$6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$14.93M derived: sum of 2 quarters · filed 2023-02-22 | -$23.05M derived: sum of 3 quarters · filed 2023-08-10 | -$32.06M 10-K · filed 2023-02-22 |
| 2022-09-30 | -$8.49M 10-Q · filed 2022-11-14 | -$16.61M derived: sum of 2 quarters · filed 2023-08-10 | -$25.63M 10-Q · filed 2022-11-14 | -$33.75M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | -$8.12M 10-Q · filed 2023-08-10 | -$17.16M 10-Q · filed 2023-08-10 | -$25.25M derived: sum of 3 quarters · filed 2023-08-10 | -$32.56M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$9.04M 10-Q · filed 2023-05-15 | -$17.14M derived: sum of 2 quarters · filed 2023-05-15 | -$24.44M derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$15.40M derived: sum of 2 quarters · filed 2023-02-22 | -$28.92M 10-K · filed 2023-02-22 | |
| 2021-09-30 | -$7.30M 10-Q · filed 2022-11-14 | -$20.83M 10-Q · filed 2022-11-14 |